The University of Wisconsin participated in a trial to test AstraZeneca’s COVID-19 vaccine. Though AstraZeneca reported a high efficacy rate, health officials have recently raised concerns about the data used to draw this conclusion. In an email to The Badger Herald, UW COVID-19 Convalescent Plasma Program’s Principal Investigator William Hartman said UW was selected as … Continue reading UW participated in under-review AstraZeneca vaccine trial